ArticleVirology journal2009

FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.

William A Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.